Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mite immunotherapy.

Enrique Fernández-Caldas1, Victor Iraola, Manuel Boquete

  • 1Laboratorios LETI, SL, Calle del Sol,5, 28760 Tres Cantos, Madrid, Spain. efernandez@leti.com

Current Allergy and Asthma Reports
|August 11, 2006
PubMed
Summary

Specific immunotherapy using house dust mite extracts offers clinical benefits for allergic conditions like asthma and rhinitis. Ongoing research aims to improve allergen delivery methods for safer and more effective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jun o 1, a Cross-reactive Juniperus oxycedrus Allergen With Unique Structural and Immunogenic Properties.

Journal of investigational allergology & clinical immunology·2026
Same author

Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Two combinations of house dust mite allergens show similar performance than extracts for asthma diagnosis.

Frontiers in allergy·2026
Same author

HLA-A*29:177: A Variant Potentially Arising From Recombination Between HLA-A and HLA-G.

HLA·2026
Same author

Plitidepsin in combination with dexamethasone (ADMYRE trial) versus an external control arm of pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Annals of hematology·2026
Same author

Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Journal of clinical medicine·2025

Area of Science:

  • Allergen immunotherapy
  • Immunology
  • Environmental Allergens

Background:

  • House dust mites (Dermatophagoides pteronyssinus and D. farinae) are primary indoor allergens globally.
  • Allergic individuals, particularly in humid regions, are frequently sensitized to these common mites.
  • Existing immunotherapy protocols often utilize aluminum hydroxide-adsorbed or chemically modified mite extracts.

Purpose of the Study:

  • To review the efficacy and safety of house dust mite immunotherapy.
  • To evaluate different immunotherapy delivery methods, including subcutaneous and sublingual routes.
  • To identify challenges and future directions in mite immunotherapy.

Main Methods:

  • Review of double-blind, placebo-controlled trials on mite immunotherapy.

Related Experiment Videos

  • Analysis of studies using subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
  • Assessment of safety profiles compared to other allergen immunotherapy types.

    • Main Results:

    • Mite immunotherapy, both SCIT and SLIT, shows clinical benefits for allergic rhinoconjunctivitis, asthma, and rhinitis in pediatric and adult patients.
    • SCIT efficacy is also demonstrated in atopic dermatitis, though further research is required.
    • Current data does not indicate significant differences in safety risks compared to immunotherapy with other allergens.

    Conclusions:

    • House dust mite immunotherapy is an effective treatment for allergic respiratory diseases.
    • Further research is needed to optimize allergen delivery systems for high-dose administration without severe adverse reactions.
    • Developing safer and more effective mite immunotherapy modalities remains a key challenge.